These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7578380)

  • 1. Management of diarrhea induced by tumors or cancer therapy.
    Cascinu S
    Curr Opin Oncol; 1995 Jul; 7(4):325-9. PubMed ID: 7578380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidiarrheal agents for the management of treatment-related diarrhea in cancer patients.
    Ippoliti C
    Am J Health Syst Pharm; 1998 Aug; 55(15):1573-80. PubMed ID: 9706182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315.
    Zachariah B; Gwede CK; James J; Ajani J; Chin LJ; Donath D; Rosenthal SA; Kane BL; Rotman M; Berk L; Kachnic LA
    J Natl Cancer Inst; 2010 Apr; 102(8):547-56. PubMed ID: 20339140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study.
    Yavuz MN; Yavuz AA; Aydin F; Can G; Kavgaci H
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):195-202. PubMed ID: 12182992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
    Rosenoff SH
    Eur J Cancer Care (Engl); 2004 Sep; 13(4):380-3. PubMed ID: 15305907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide in the treatment of severe chemotherapy-induced diarrhea.
    Zidan J; Haim N; Beny A; Stein M; Gez E; Kuten A
    Ann Oncol; 2001 Feb; 12(2):227-9. PubMed ID: 11300329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommended guidelines for the treatment of cancer treatment-induced diarrhea.
    Benson AB; Ajani JA; Catalano RB; Engelking C; Kornblau SM; Martenson JA; McCallum R; Mitchell EP; O'Dorisio TM; Vokes EE; Wadler S
    J Clin Oncol; 2004 Jul; 22(14):2918-26. PubMed ID: 15254061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
    Rosenoff SH; Gabrail NY; Conklin R; Hohneker JA; Berg WJ; Warsi G; Maloney J; Benedetto JJ; Miles EA; Zhu W; Anthony L
    J Support Oncol; 2006 Jun; 4(6):289-94. PubMed ID: 16805331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.
    Hoff PM; Saragiotto DF; Barrios CH; del Giglio A; Coutinho AK; Andrade AC; Dutra C; Forones NM; Correa M; Portella Mdo S; Passos VQ; Chinen RN; van Eyll B
    J Clin Oncol; 2014 Apr; 32(10):1006-11. PubMed ID: 24516038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy-induced diarrhea].
    Kobayashi K
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):765-71. PubMed ID: 12852342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy- and radiotherapy-induced diarrhea.
    Muehlbauer PM; Thorpe D; Davis A; Drabot R; Rawlings BL; Kiker E
    Clin J Oncol Nurs; 2009 Jun; 13(3):336-41. PubMed ID: 19502193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide does not prevent diarrhea in patients treated with weekly 5-fluorouracil plus high-dose leucovorin.
    Meropol NJ; Blumenson LE; Creaven PJ
    Am J Clin Oncol; 1998 Apr; 21(2):135-8. PubMed ID: 9537197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of chemotherapy induced diarrhea].
    Schultz M; Schölmerich J; Kullmann F
    Z Gastroenterol; 2004 Jun; 42(6):527-38. PubMed ID: 15190449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy in diarrheal diseases in oncology/hematology patients.
    Cascinu S
    Crit Rev Oncol Hematol; 1995 Jan; 18(1):37-50. PubMed ID: 7695823
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of octreotide in post chemotherapy and/or radiotherapy diarrhea: prophylaxis or therapy?
    Sun JX; Yang N
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e108-13. PubMed ID: 23297685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing chemotherapy-induced diarrhea.
    Saltz LB
    Clin Adv Hematol Oncol; 2006 Mar; 4(3):203-4. PubMed ID: 16728928
    [No Abstract]   [Full Text] [Related]  

  • 17. Octreotide in the management of treatment-related diarrhoea.
    Baillie-Johnson HR
    Anticancer Drugs; 1996 Jan; 7 Suppl 1():11-5. PubMed ID: 8822080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma.
    Petrelli NJ; Rodriguez-Bigas M; Rustum Y; Herrera L; Creaven P
    Cancer; 1993 Sep; 72(5):1543-6. PubMed ID: 8348489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic diarrhea: evaluation and treatment.
    Lipsky MS; Adelman M
    Am Fam Physician; 1993 Dec; 48(8):1461-6. PubMed ID: 8249777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous octreotide infusion for the treatment of secretory diarrhea caused by acute intestinal graft-versus-host disease in a child.
    Beckman RA; Siden R; Yanik GA; Levine JE
    J Pediatr Hematol Oncol; 2000; 22(4):344-50. PubMed ID: 10959906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.